2023 ISPE Pharma 4.0™ and Annex 1 Conference

Thank you to all who made the 2023 ISPE Pharma 4.0™ and Annex 1 Conference such a big success!


Please Note:

  • All full-access registration (virtual & in-person) includes access to speaker presentations, on-demand content, and other conference material.
  • NOTE: Material is only available from those speakers/companies that permitted distribution.
  • Registrants will receive email notification when the on-demand content is available.
  • On-demand content is accessible for 90 days.

Access Conference Platform


 

Technical Presentation

Pharma 4.0™ Integration

Discover how Pharma 4.0™ principles and digitalization transform operations, quality, and maintenance within the pharmaceutical landscape.

Technical Presentation

Annex 1 Implementation

Learn strategies for implementing the latest Annex 1 version through real-world case studies, ensuring smooth operational changes and hardware integration.

Case Studies

Automation

Dive into the impact of automation on cutting-edge processes like ATMPs and gene therapy, redefining how we work.

Case Studies

Rapid Monitoring and Testing

Uncover how rapid microbial monitoring enhances quality control precision and streamlines supply chains.

Case Studies

Expert Insights

Hear from industry leaders and regulators who will share their perspectives on the future of pharmaceuticals.


Keynote Speakers

Maria Jesus Lamas Diaz
Director
AEMPS (Spanish Agency of Medicines and Healthcare Products)
Evdokia Korakianiti
Head of Quality and Safety of Medicines
EMA
Christoph Prinz
Vice President Global Operational Quality
BioNTech
Teresa Minero
Founder & CEO
LifeBee - Digitalizing Life Sciences
Christian Wölbeling
Executive Industry Advisor
Körber Pharma Software GmbH

View All Speakers


2023 ISPE Pharma 4.0™ and Annex 1 Conference Gallery



Conference Highlights


Receive Notifications

Stay up-to-date on registration, education opportunities, speakers, hotel discounts, exhibitor information, and more by signing up to receive notifications for the 2024 ISPE Pharma 4.0™ and Annex 1 Conference.

Name
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Company Type

Programme Committee

Cristina Mazo
QP - Site Manager
GP Pharma
Chair - Pharma 4.0
Jörg Zimmermann
Vice President Vetter Development Service External Affairs
Vetter Pharma Fertigung GmbH & Co KG
Chair - Annex 1
Nuha Al-Hafez
Quality Fundamentals Area Lead
Roche
Maria Amaya
Lead External Advocacy North America (Quality Policy)
Genentech, A Member of the Roche Group
Emerging Leader
Richard Denk
Senior Consultant Aseptic Processing & Containment
SKAN AG
Yvonne Duckworth, PE
Fellow - Digital Technology, Associate
CRB
Jean Francois Duliere
Reg Advisor
ISPE
Matthew P. Gorton
Director of Business Development
GBA Life Sciences
Felix Kern
Associate Director - Head of Compliance Launch and Technology Center
Merck KGaA
Violeta Mihailova
Sr. QA Specialist
Bristol Myers Squibb
Emerging Leader
Teresa Minero
Founder & CEO
LifeBee - Digitalizing Life Sciences
Placeholder Person Graphic
Isabel Garcia Mora
Quality Assurance Project Manager
Lonza AG
Emerging Leader
Line Lundsberg-Nielsen, PhD
Managing Consultant, Compliance Consulting
NNE
Heike Roeder
Vice President QA International
Cencora
Placeholder Person Graphic
Pol Bonet Sune
Project Advisor
Aseptic Mind
Emerging Leader
Alicia Tébar
Founder. QbD & GMP Consultant
QbD Pharmaceutical Services SL
Placeholder Person Graphic
Sofie Strejby Thomsen
Junior Consultant, Facility Operations
NNE
Emerging Leader
Josef Trapl
Managing Director
Memo3 GmbH
Stephen Wing
Head of Analytical & Logistical Services
Merck KGaA
Wolfgang Winter
Software Framework R&D Director
Agilent Technologies Deutschland GmbH
Christian Wölbeling
Executive Industry Advisor
Körber Pharma Software GmbH

AnchorMedia Sponsors

IPQ

AnchorConference Sponsors

Belimed Life Science
Zeta